T1	intervention 21 35	oral magnesium
T2	condition 39 58	postmastectomy pain
T3	No-of-participants 1019 1022	100
T4	eligibility 1023 1069	women with breast cancer undergoing mastectomy
T5	location 1114 1120	France
T6	control 1154 1161	placebo
T7	intervention-participants 1147 1149	50
T8	control-participants 1165 1167	50
T9	duration 1194 1201	6 weeks
T10	outcome-Measure 1236 1253	Intensity of pain
T11	outcome-Measure 1255 1287	cognitive and emotional function
T12	outcome-Measure 1292 1307	quality of life
T13	outcome-Measure 1368 1442	pain intensity on a 0-10 numerical rating scale at 1â€‰month postmastectomy.
